SPHK2 and atherosclerosis: Genetic disruption of SphK2 in mouse models has been reported to exacerbate atherosclerosis [32], thus epigenetic regulation of ABCA1 and LXR target genes by SphK2 may be the key to understanding the anti-atherogenic mechanism of FTY720.